TY - JOUR
T1 - Association of the Verbal Rating Scale-Measured Dysmenorrhea with Nausea and Vomiting in Pregnancy
T2 - A Retrospective Cohort Study
AU - Zhang, Xiaolei
AU - Zhang, Yanling
AU - Lv, Dan
AU - Xie, Yin
AU - Xu, Heze
AU - Li, Fanfan
AU - He, Mengzhou
AU - Fan, Yao
AU - Li, Xufang
AU - Jallow, Fatoumata
AU - Li, Wei
AU - Lin, Xingguang
AU - Ye, Fang
AU - Deng, Dongrui
N1 - Publisher Copyright:
© 2024 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada
PY - 2024/5
Y1 - 2024/5
N2 - Objectives: Nausea and vomiting in pregnancy (NVP) is a common condition that reduces the quality of life by negatively affecting work and family life, physical and mental health, and economic well-being. However, its risk factors remain unclear. This study aimed to explore the association between NVP and verbal rating scale (VRS)-measured dysmenorrhea and to explore potential protective factors. Methods: This retrospective cohort study was conducted from June 2018 to December 2020 at Tongji Hospital in Wuhan. Information on baseline characteristics, pregnancy-related history, periconceptional micronutrient supplementation, and obstetric outcomes were collected. The severity of dysmenorrhea was assessed using VRS. Results: A total of 443 pregnant women were recruited and divided into the NVP group (n = 76) and the control group (n = 367). A significant association was observed between NVP and VRS-measured dysmenorrhea (c2=10.038, P = 0.007). After adjusting for covariates, the association between moderate/severe dysmenorrhea and NVP remained significant (OR 2.384; 95% CI 1.104–5.148, P = 0.004). First-trimester docosahexaenoic acid supplement (OR 0.443; 95% CI 0.205–0.960, P = 0.039) may be beneficial in reducing the risk of NVP. Conclusions: Women with moderate to severe dysmenorrhea have a higher risk of experiencing NVP during the first trimester. Periconceptional docosahexaenoic acid supplementation may play a protective role.
AB - Objectives: Nausea and vomiting in pregnancy (NVP) is a common condition that reduces the quality of life by negatively affecting work and family life, physical and mental health, and economic well-being. However, its risk factors remain unclear. This study aimed to explore the association between NVP and verbal rating scale (VRS)-measured dysmenorrhea and to explore potential protective factors. Methods: This retrospective cohort study was conducted from June 2018 to December 2020 at Tongji Hospital in Wuhan. Information on baseline characteristics, pregnancy-related history, periconceptional micronutrient supplementation, and obstetric outcomes were collected. The severity of dysmenorrhea was assessed using VRS. Results: A total of 443 pregnant women were recruited and divided into the NVP group (n = 76) and the control group (n = 367). A significant association was observed between NVP and VRS-measured dysmenorrhea (c2=10.038, P = 0.007). After adjusting for covariates, the association between moderate/severe dysmenorrhea and NVP remained significant (OR 2.384; 95% CI 1.104–5.148, P = 0.004). First-trimester docosahexaenoic acid supplement (OR 0.443; 95% CI 0.205–0.960, P = 0.039) may be beneficial in reducing the risk of NVP. Conclusions: Women with moderate to severe dysmenorrhea have a higher risk of experiencing NVP during the first trimester. Periconceptional docosahexaenoic acid supplementation may play a protective role.
KW - DHA
KW - dysmenorrhea
KW - nausea and vomiting in pregnancy
KW - nutrient supplementation
KW - verbal rating scales
UR - http://www.scopus.com/inward/record.url?scp=85186526889&partnerID=8YFLogxK
U2 - 10.1016/j.jogc.2024.102406
DO - 10.1016/j.jogc.2024.102406
M3 - 文章
C2 - 38331093
AN - SCOPUS:85186526889
SN - 1701-2163
VL - 46
JO - Journal of Obstetrics and Gynaecology Canada
JF - Journal of Obstetrics and Gynaecology Canada
IS - 5
M1 - 102406
ER -